Contact
Please use this form to send email to PR contact of this press release:
Catalyst Biosciences Announces Interim Phase 1/2 CB 2679d/ISU304 Results at the American Society of Hematology Conference
TO:
Please use this form to send email to PR contact of this press release:
Catalyst Biosciences Announces Interim Phase 1/2 CB 2679d/ISU304 Results at the American Society of Hematology Conference
TO: